vTv Therapeutics Inc.
VTVT
$22.23
-$0.27-1.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.46M | -18.31M | -20.18M | -20.62M | -20.25M |
| Total Depreciation and Amortization | 89.00K | 90.00K | 90.00K | 90.00K | 90.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.50M | -2.24M | -25.00K | -1.29M | -3.32M |
| Change in Net Operating Assets | -5.44M | -2.94M | -1.70M | 569.00K | 4.39M |
| Cash from Operations | -25.31M | -23.40M | -21.81M | -21.25M | -19.08M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 4.40M | 4.40M | 4.40M | 4.40M |
| Cash from Investing | -- | 4.40M | 4.40M | 4.40M | 4.40M |
| Total Debt Issued | -- | 0.00 | 566.00K | 566.00K | 566.00K |
| Total Debt Repaid | -191.00K | -473.00K | -566.00K | -566.00K | -599.00K |
| Issuance of Common Stock | 52.80M | 52.80M | 50.34M | 50.34M | 12.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 52.61M | 52.33M | 50.34M | 50.34M | 12.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.30M | 33.33M | 32.93M | 33.49M | -2.68M |